Related Experiment Video
Updated: Jul 7, 2025
Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
When Atrial Fibrillation Meets Cerebral Amyloid Angiopathy: Current Evidence and Strategies
Pierluigi Merella1, Gavino Casu1,2, Paola Chessa3
1Department of Cardiology, Azienda Ospedaliero Universitaria di Sassari, Via De Nicola 1, 07100 Sassari, Italy.
Insights
Elderly patients with atrial fibrillation (AF) on anticoagulants face high intracranial hemorrhage risk from cerebral amyloid angiopathy (CAA). Early diagnosis via MRI can prevent severe bleeding complications.
Area of Science:
- Neurology
- Geriatrics
- Pharmacology
Background:
- Non-valvular atrial fibrillation (AF) and cerebral amyloid angiopathy (CAA) are prevalent in the elderly.
- Anticoagulant therapy prevents stroke in AF but increases intracranial hemorrhage (ICH) risk.
- CAA is a major risk factor for spontaneous ICH, especially with age and antithrombotics.
Purpose of the Study:
- To equip physicians with knowledge on recognizing cerebral amyloid angiopathy in AF patients.
- To highlight clinical presentations and diagnostic criteria for CAA.
- To reduce ICH complications in patients on anticoagulant therapy.
Main Methods:
- Review of clinical presentations of cerebral amyloid angiopathy.
- Discussion of diagnostic criteria for cerebral amyloid angiopathy.
- Focus on non-contrast MRI for diagnosing cerebral amyloid angiopathy.
Main Results:
- Cerebral amyloid angiopathy can present as TIA-mimics or stroke in AF patients.
- Unknown CAA diagnosis can lead to increased ICH risk when anticoagulants are initiated.
- Non-contrast MRI is effective for diagnosing cerebral amyloid angiopathy.
Conclusions:
- Suspecting and diagnosing cerebral amyloid angiopathy early is crucial for preventing ICH.
- Physicians managing anticoagulation need familiarity with CAA's clinical and diagnostic aspects.
- Early CAA detection via MRI can mitigate catastrophic bleeding events in AF patients.
Abstract:
Non-valvular atrial fibrillation (AF) and cerebral amyloid angiopathy (CAA) are two common diseases in elderly populations. Despite the effectiveness of oral anticoagulant therapy in cardioembolic stroke prevention, intracranial hemorrhage represents the most serious complication of these therapies. Cerebral amyloid angiopathy is one of the main risk factors for spontaneous intracranial bleeding, and this risk is highly increased by age and concomitant antithrombotic therapies. Cerebral amyloid angiopathy can be silent for years and then manifest with clinical features simulating TIA (TIA-mimics) or stroke in AF patients, pushing clinicians to rapidly start VKAs or DOACs, thus increasing the risk of intracranial bleeding if the diagnosis of CAA was unknown. Because the cerebral amyloid angiopathy is easily diagnosed with non-contrast MRI, suspecting the disease can avoid catastrophic complications. In this review, we will provide physicians managing anticoagulant therapies with key tips to familiarize themselves with cerebral amyloid angiopathy, with a focus on the possible clinical presentations and on the diagnostic criteria.
